SSNC Technologies Holdings is a global provider of software and technology-enabled services for the financial services and healthcare industries. Its quarterly report offers a broad read on spending across asset management, insurance, banking, and healthcare technology, making the release a useful barometer for enterprise software demand. Heading into the report, investors were watching whether SSNC could sustain its recent momentum in organic growth while protecting its industry-leading margins. The Q3 2026 results showed continued top-line expansion and record profitability, but a fourth-quarter revenue outlook that came in below consensus shifted attention to the pace of growth ahead. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter ended September 30, 2026, SSNC posted adjusted revenue of $1.691 billion, a 7.8% increase from $1.568 billion in the prior-year period. On a GAAP basis, total revenue was $1.69 billion, also up 7.8%. Adjusted organic revenue growth, which excludes acquisitions and currency effects, was 5.2% on a constant-currency basis.
Adjusted diluted EPS rose 14.8% to $1.78, up from $1.57 a year earlier and modestly above the $1.77 consensus estimate. GAAP diluted EPS was $0.83, unchanged year over year, while GAAP net income attributable to common stockholders declined to $198.9 million from $210.0 million. The divergence between GAAP and adjusted figures largely reflects acquisition-related amortization and other items.
Profitability remained a highlight. Adjusted consolidated EBITDA reached a record $674.8 million, up 9% year over year, with an adjusted EBITDA margin of 39.9%, an improvement of 40 basis points. GAAP operating income rose 11.9% to $409.3 million, for a 24.2% operating margin.
Looking ahead, management guided fourth-quarter adjusted revenue to $1.70 billion to $1.74 billion and adjusted diluted EPS to $1.88 to $1.94. For full-year 2026, the company raised its outlook to adjusted revenue of $6.736 billion to $6.776 billion and adjusted diluted EPS of $7.11 to $7.17.
Despite beating adjusted EPS expectations and delivering record EBITDA, SSNC shares moved lower in after-hours trading, falling roughly 6% to around $84. The reaction suggests investors were more focused on the forward-looking guidance than the headline results. While adjusted earnings came in slightly ahead of consensus, the midpoint of the company's fourth-quarter revenue outlook of $1.72 billion sat below the roughly $1.75 billion analysts had modeled, raising questions about near-term growth momentum. The modest full-year EPS guidance raise was not enough to offset concerns about the softer revenue trajectory into the final quarter of the year.
Investors will be watching several signals in the quarters ahead. First, the sustainability of organic growth is central. Management pointed to 5.2% adjusted organic revenue growth and a 4% organic growth target at the midpoint of fourth-quarter guidance, indicating a measured pace that the market may continue to scrutinize.
Second, margin execution remains a key strength worth monitoring. SSNC delivered record adjusted EBITDA and margin expansion in Q3, and its ability to hold or build on a roughly 40% EBITDA margin will influence profitability even if top-line growth moderates.
Third, capital allocation and the balance sheet deserve attention. The company repurchased shares, paid dividends, and reduced debt during the quarter, and its leverage position will be a factor as it manages upcoming debt maturities.
Finally, broader demand trends across financial services and healthcare technology will shape the outlook. Any shift in client spending on software and technology-enabled services could affect both revenue growth and guidance. None of this constitutes a price forecast or investment recommendation, but these are the operational and financial themes most likely to drive the next phase of the stock's story.
In my analysis of names like SSNC, I often turn to Tickeron’s AI Screener to quickly filter peers and spot relevant technical or fundamental setups. The tool lets me scan thousands of stocks and ETFs with customizable filters for industry, patterns, and performance metrics, helping surface ideas and monitor conditions more efficiently than manual reviews. It has become a regular part of my process when evaluating quarterly results and sector trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
SSNC moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend. In 27 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 73%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on SSNC as a result. In 46 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for SSNC just turned positive on October 08, 2026. Looking at past instances where SSNC's MACD turned positive, the stock continued to rise in 28 of 49 cases over the following month. The odds of a continued upward trend are 57%.
The 10-day moving average for SSNC crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +2.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where SSNC advanced for three days, in 168 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SSNC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
SSNC broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for SSNC entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. SSNC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 63 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.077) is normal, around the industry mean (-1.402). P/E Ratio (24.327) is within average values for comparable stocks, (14.914). Projected Growth (PEG Ratio) (0.731) is also within normal values, averaging (2.824). Dividend Yield (0.014) settles around the average of (0.072) among similar stocks. P/S Ratio (3.052) is also within normal values, averaging (71.128).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of software products and software enabled services
Industry PackagedSoftware